Blood–brain barrier properties of human immunodeficiency virus antiretrovirals
- 1 October 1999
- journal article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 88 (10) , 950-954
- https://doi.org/10.1021/js990174i
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- In Vitro Blood–Brain Barrier Permeability of Nevirapine Compared to Other HIV Antiretroviral AgentsJournal of Pharmaceutical Sciences, 1998
- Dementia Associated with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1995
- The role of the blood-brain barrier in HIV infection of the central nervous systemAdvances in Neuroimmunology, 1994
- HIV infection of human brain capillary endothelial cell — Implications for AIDS dementiaAdvances in Neuroimmunology, 1994
- Cerebral white matter changes in acquired immunodeficiency syndrome dementia: Alterations of the blood‐brain barrierAnnals of Neurology, 1993
- HUMAN IMMUNODEFICIENCY VIRUS AND THE CENTRAL NERVOUS SYSTEMAnnual Review of Microbiology, 1992
- Early viral brain invasion in iatrogenic human immunodeficiency virus infectionNeurology, 1992
- High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patientsNature, 1990
- Absence of Immorally mediated damage within the central nervous system of AIDS patientsNeurology, 1989
- Characterization of an In Vitro Blood–Brain Barrier Model System for Studying Drug Transport and MetabolismPharmaceutical Research, 1986